AI assistant
Sending…
Tharimmune, Inc. — Director's Dealing 2025
Nov 14, 2025
34824_dirs_2025-11-14_54a28710-c90e-4f6f-853d-40d91b33f4ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-11-06
Reporting Person: Wendland Mark Paul (Chief Executive Officer)
More from Tharimmune, Inc.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11